Home
>
News
>
Corporate Results
>
vivanza biosciences reports consolidated net loss of rs 0 45 crore in the march 2026 quarter

Vivanza Biosciences Reports Consolidated Net Loss Of Rs 0.45 Crore In The March 2026 Quarter

08-May-26 07:36 Hrs IST

Net Loss of Vivanza Biosciences reported to Rs 0.45 crore in the quarter ended March 2026 as against net loss of Rs 1.00 crore during the previous quarter ended March 2025. Sales rose 1225.00% to Rs 6.36 crore in the quarter ended March 2026 as against Rs 0.48 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.39 crore in the year ended March 2026 as against net loss of Rs 0.67 crore during the previous year ended March 2025. Sales rose 1462.13% to Rs 115.91 crore in the year ended March 2026 as against Rs 7.42 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	6.36	0.48	1225	115.91	7.42	1462
OPM %	-3.62	-200.00	-	0.63	-4.85	-
PBDT	-0.29	-0.99	71	0.57	-0.65	LP
PBT	-0.30	-0.99	70	0.54	-0.67	LP
NP	-0.45	-1.00	55	0.39	-0.67	LP

Powered by Capital Market - Live News

Invest with clarity

on Chola Securities Mobile & Web App.

Stay organised, informed & in control while accessing your portfolio, reports, trading tools and service requests—all in one seamless platform.

Download the app now → The new app is listed as Chola Securities- Prime Access on App store & Google Play.
Also available on Web, Click to explore